Activaero appoints Christian Pangratz chief business officer
This article was originally published in Scrip
Activaero, a German company dealing in controlled breathing inhalation technologies and therapeutics, has appointed Christian Pangratz chief business officer. He will lead all business development, marketing and alliance management activities. His most recent position was executive director of business development at Nektar Therapeutics.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.